Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018119 · ClinicalTrials.gov registry record · NA
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
A NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03018119: Completed NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage, sponsored by Brigham and Women's Hospital.
NCT03018119 is a NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 38 participants, below the 778-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03018119, a NA study of Postpartum Hemorrhage and Pregnancy Hemorrhage, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The National Partnership for Maternal Safety (NPMS) developed an obstetric hemorrhage consensus bundle to provide every United States birthing facility consistent, validated practice guidelines. To facilitate implementation of each element of this bundle at the participants large tertiary center, the investigators utilized the Delphi method to identify deficiencies, perceived barriers to implementation, and multidisciplinary consensus on changes with high feasibility and impact on patient care.
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT03018119 record still lists
NCT03018119 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 778-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT03018119 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03018119 about?
NCT03018119 is a clinical study titled "Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method". The National Partnership for Maternal Safety (NPMS) developed an obstetric hemorrhage consensus bundle to provide every United States birthing facility consistent, validated practice guidelines. To facilitate implementation of each element of this bundle at the participants large tertiary center, th...
What is the current status of trial NCT03018119?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2015-11. Estimated completion is 2016-04.
What conditions does trial NCT03018119 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage, Pregnancy Hemorrhage.
What interventions are being tested in trial NCT03018119?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT03018119?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03018119 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03018119's enrollment target sits among peer trials
38 18th of 19 higher than 2 of 19 other Postpartum Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia